Artificial Intelligence in Neurobiology and Neurologic Diseases

admin
3 Min Read

School of Computer Science and Engineering, Central South University, Changsha, China

Interests: medical image analysis; deep learning; machine learning; computer vision

Millions of people are affected by neurological disorders. Patients with this condition have lots of limitations impacting not just their life but also their caregivers. Early detection of the condition can be improved with the help of Artificial Intelligence (AI) based techniques. AI is having a disruptive and transformative effect on clinical medicine. For neurology and neurobiology, there have been increasing interests in developing models and tools to address the complex patterns of connectivity in brain tissue. Cutting-edge AI-based approaches provide great opportunities for making new discoveries about the brain, improving current preventative and diagnostic models and developing more effective assistive neurotechnologies. This special issue focuses on current AI-driven approaches to clinical neuroscience and an assessment of the associated key methodological and ethical challenges. The fundamentals of AI in neurobiology and neurology, its applications and use cases in various areas of neurobiology and neurology and how AI-based algorithms can transform the management of neurological diseases will be favored. Research implications, novel methods involving deep learning models, AI-based neuroimaging using brain scans to detect neurological disease will be highlighted.

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI’s English editing service prior to publication or during author revisions.

Share This Article
By admin
test bio
Leave a comment